Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00392223
Status:
TERMINATED
Last Update Posted:
2010-01-12
First Post:
2006-10-23
Brief Title:
Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase III Multicenter Randomized Double Blind-Double Dummy Study To Evaluate Efficacy And Safety Of Treatment With Azithromycin Microspheres Oral Powder For Suspension 2 G In One Administration A Week For 8 Weeks Compared With Treatment With Minocycline Capsules 100 Mg Die For 8 Weeks In Outpatients With Moderate To Severe Inflammatory Acne
Status:
TERMINATED
Status Verified Date:
2010-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
See Detailed Description
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective is to evaluate the clinical efficacy of azithromycin microspheres treatment in outpatients with moderate to severe inflammatory acne compared with first line treatment minocycline after 8 weeks of therapy
Detailed Description:
The study prematurely discontinued on the February 1 2008 due to slow enrollmentIt should be noted that safety concerns have not been seen in this study and have not factored into this decision
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None